Washington Cancer Institute at MedStar Washington Hospital Center

Washington, District of Columbia 20010

We've found

1 trials

at this facility

A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Washington DC,

Use our guide to learn which trials are right for you!